THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS
- 1 May 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8436), 999-1002
- https://doi.org/10.1016/s0140-6736(85)91610-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MANThe Lancet, 1984
- Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsThrombosis Research, 1984
- A functional assay of protein C in human plasmaBlood, 1984
- IMPORTANCE OF HLA-DR MATCHING IN POLYTRANSFUSED CADAVERIC KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1983
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- Reduced Generation of Procoagulant Activity by Endotoxin-stimulated Mononuclear Cells from Patients with Chronic Myeloid LeukaemiaBritish Journal of Haematology, 1981
- A Radioimmunoassay to Measure Cyclosporin a in Plasma and Serum SamplesJournal of Immunoassay, 1981
- Increase in Fibrinogen and Fibrin-Related Antigen in Human Serum Due to In Vitro Lysis of Fibrin by ThrombinJCI Insight, 1972
- A Simple Method for the Assay of Factor VIII, Using 20 Microlitres of Capillary BloodBritish Journal of Haematology, 1968
- A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1963